Sutro Biopharma (STRO) Stock Highlights

3.95 | -1.5%

2024-09-19 04:44:14

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Statistics

Range Today

3.9 4.21

Volume Today 547.7K

Range 1 Year

2.01 6.13

Volume 1 Year 208.48M

Range 3 Year

2.01 23.7

Volume 3 Year 461.01M

Range 10 Year

2.01 28.3

Volume 10 Year 622.26M

Highlights

Market Capitalization 368.84M (small)

Floating Shares 64.56M

Current Price 3.95

Price To Earnings -2.54

Price To Revenue -0.18

Price To Book 2.42

Earnings Per Share -1.78

Payout Ratio 0%

Performance

Latest -1.5%

1 Month -5.28%

3 Months +22.67%

6 Months -3.42%

1 Year +1.02%

3 Years -79.76%

5 Years -64.12%

10 Years -73.88%

Benchmarks

Market Capitalization

195 / 368

Gross Profits

0 / 278

Total Revenue

124 / 300

Total Rank

270 / 368

Free Cashflow

265 / 352

Performance 5 years

204 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.